evolutions in the treatment of egfr-mutated nsclc
Published 5 years ago • 60 plays • Length 2:02Download video MP4
Download video MP3
Similar videos
-
3:28
treating beyond progression in egfr-mutant lung cancer
-
4:02
treatment of egfr mutated nsclc - 2022 program: targeted therapies forum - english
-
5:52
treatment of egfr nsclc after osimertinib
-
3:16
dr herbst on the evolution of targeted therapies for egfr nsclc
-
1:57
dr. wakelee on benefits of osimertinib in egfr-mutant nsclc treatment
-
4:04
treating with osimertinib in egfr-mutated nsclc
-
6:56
first-line therapy in the patient with egfr-mutant lung cancer
-
3:30
osimertinib for uncommon egfr mutations in nsclc
-
6:57
egfr exon 20 mutations in non–small cell lung cancer
-
5:55
surgery options for nsclc & i-o therapy in egfr-mutations
-
3:24
sequencing of therapies in egfr-mutant nsclc
-
0:59
dr. west on emerging changes in the field of egfr-mutant nsclc
-
3:02
osimertinib in advanced egfr t790m-mutant nsclc
-
1:14
evaluating the role of egfr mutations in the treatment of advanced nsclc
-
1:58
dr. bazhenova on sequencing beyond progression in egfr-mutant nsclc
-
2:10
reconsideration of gefitinib in egfr-mutant nsclc
-
1:13
the impact of p53 mutation on survival in egfr-mutated nsclc patients
-
5:02
egfr-mutant lung cancer: initial approach
-
1:02:40
new milestones and changing standards of care in early egfr-mutated nsclc